c-Jun and p53 activity is modulated by SUMO-1 modification - PubMed (original) (raw)
. 2000 May 5;275(18):13321-9.
doi: 10.1074/jbc.275.18.13321.
Affiliations
- PMID: 10788439
- DOI: 10.1074/jbc.275.18.13321
Free article
c-Jun and p53 activity is modulated by SUMO-1 modification
S Muller et al. J Biol Chem. 2000.
Free article
Abstract
The ubiquitin-related SUMO-1 molecule has been shown recently to modify covalently a number of cellular proteins including IkappaBalpha. SUMO-1 modification was found to antagonize IkappaBalpha ubiquitination and protect it from degradation. Here we identify the transcription factors c-Jun and p53, two well known targets of ubiquitin, as new substrates for SUMO-1 both in vitro and in vivo. In contrast to ubiquitin, SUMO-1 preferentially targets a single lysine residue in c-Jun (Lys-229), and the abrogation of SUMO-1 modification does not compromise its ubiquitination. Activation of Jun NH(2)-terminal kinases, which induces a reduction in c-Jun ubiquitination, similarly decreases SUMO-1 modification. Accordingly, loss of the two major Jun NH(2)-terminal kinase phosphorylation sites in c-Jun, Ser-63 and Ser-73, greatly enhances conjugation by SUMO-1. A SUMO-1- deficient c-JunK229R mutant shows an increased transactivation potential on an AP-1-containing promoter compared with wild-type c-Jun, suggesting that SUMO-1 negatively regulates c-Jun activity. As with c-Jun, SUMO-1 modification of p53 is abrogated by phosphorylation but remains unaltered upon chemical damage to DNA or Mdm2-mediated ubiquitination. The SUMO-1 attachment site in p53 (Lys-386) resides within a region known to regulate the DNA binding activity of the protein. A p53 mutant, defective for SUMO-1 conjugation, shows unaltered ubiquitination but has a slightly impaired apoptotic activity, indicating that modification by SUMO-1 might be important for the full biological activity of p53. Taken together, these data provide a first link between the SUMO-1 conjugation pathway and the regulation of transcription factors.
Similar articles
- Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.
Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, Del Sal G. Gostissa M, et al. EMBO J. 1999 Nov 15;18(22):6462-71. doi: 10.1093/emboj/18.22.6462. EMBO J. 1999. PMID: 10562558 Free PMC article. - SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
Buschmann T, Fuchs SY, Lee CG, Pan ZQ, Ronai Z. Buschmann T, et al. Cell. 2000 Jun 23;101(7):753-62. doi: 10.1016/s0092-8674(00)80887-9. Cell. 2000. PMID: 10892746 Retracted. - Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
Schmidt D, Müller S. Schmidt D, et al. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2872-7. doi: 10.1073/pnas.052559499. Epub 2002 Feb 26. Proc Natl Acad Sci U S A. 2002. PMID: 11867732 Free PMC article. - SUMO protein modification.
Dohmen RJ. Dohmen RJ. Biochim Biophys Acta. 2004 Nov 29;1695(1-3):113-31. doi: 10.1016/j.bbamcr.2004.09.021. Biochim Biophys Acta. 2004. PMID: 15571812 Review. - SUMO-1 and p53.
Melchior F, Hengst L. Melchior F, et al. Cell Cycle. 2002 Jul-Aug;1(4):245-9. Cell Cycle. 2002. PMID: 12429940 Review.
Cited by
- Posttranslational Modifications of α-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases.
Hassanzadeh K, Liu J, Maddila S, Mouradian MM. Hassanzadeh K, et al. Pharmacol Rev. 2024 Oct 16;76(6):1254-1290. doi: 10.1124/pharmrev.123.001111. Pharmacol Rev. 2024. PMID: 39164116 Free PMC article. Review. - Crosstalk between SUMOylation and other post-translational modifications in breast cancer.
Wei B, Yang F, Yu L, Qiu C. Wei B, et al. Cell Mol Biol Lett. 2024 Aug 10;29(1):107. doi: 10.1186/s11658-024-00624-3. Cell Mol Biol Lett. 2024. PMID: 39127633 Free PMC article. Review. - Characterization of nucleolar SUMO isopeptidases unveils a general p53-independent checkpoint of impaired ribosome biogenesis.
Dönig J, Mende H, Davila Gallesio J, Wagner K, Hotz P, Schunck K, Piller T, Hölper S, Uhan S, Kaulich M, Wirth M, Keller U, Tascher G, Bohnsack KE, Müller S. Dönig J, et al. Nat Commun. 2023 Dec 8;14(1):8121. doi: 10.1038/s41467-023-43751-9. Nat Commun. 2023. PMID: 38065954 Free PMC article. - SENP3-mediated deSUMOylation of c-Jun facilitates microglia-induced neuroinflammation after cerebral ischemia and reperfusion injury.
Xia Q, Mao M, Zhan G, Luo Z, Zhao Y, Li X. Xia Q, et al. iScience. 2023 May 25;26(6):106953. doi: 10.1016/j.isci.2023.106953. eCollection 2023 Jun 16. iScience. 2023. PMID: 37332598 Free PMC article. - Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
Cheng X, Yang W, Lin W, Mei F. Cheng X, et al. Pharmacol Rev. 2023 Sep;75(5):979-1006. doi: 10.1124/pharmrev.122.000784. Epub 2023 May 3. Pharmacol Rev. 2023. PMID: 37137717 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous